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Folate, a water soluble B vitamin, serves as a methyl donor for the synthesis of 
nucleotides and methionine. Folate deficiency has been linked to a variety of health 
problems that include developmental defects, cancer and neurological diseases. The 
relation between folate deficiency and human health problems has not been fully 
explained. Our preliminary results and limited published data have shown that the 
activity of NF-κ B increases in folate deficient conditions. NF-κB is a cytosolic dimeric 
transcription factor that responds to a variety of stimuli by regulating genes involved in 
immune response, cell survival and cell growth. The purpose of the study was to 
determine if folate deficiency leads to altered NF-κB activity, protein levels and nuclear 
localization, and to determine the possible mechanisms behind this alteration. NIH3T3 
cells containing a NF-κB reporter construct (NF-κB-LUC-3T3 cells) were grown for 7 
and 11 days in folate sufficient and folate deficient DMEM medium either with or 
without TNF-α (stimulator of NF-κB). NF-κB activity was higher in folate deficient 
medium at days 7 and 11 in both unstimulated and stimulated cells, as measured by 
luciferase assay per unit DNA. NF-κB protein levels analyzed by Western Blot showed 
no difference between folate sufficient and deficient cells. Immunofluorescence by 
confocal microscopy showed that there was no significant change in the nuclear 
localization of NF-κB in folate deficient conditions even when stimulated with TNF-α. 
Analysis of reactive oxygen species (ROS) using a fluorescent assay with flow cytometry 
revealed that there was more fluorescence per cell in folate deficient cells at day 11. This 
increase in ROS could be one of the mechanisms behind the increase in NF-κB activity in 
folate deficient cells.         
POSSIBLE INVOLVEMENT OF NF-κB IN THE RESPONSE OF CELLS TO FOLATE 
DEFICIENCY 
 
 
 
By  
Rashmi Ranjana 
 
 
 
A Thesis Submitted to 
The Faculty of The Graduate School at 
The University of North Carolina at Greensboro 
In Partial Fulfillment 
Of the Requirements for the Degree 
Master of Science 
 
 
 
Greensboro  
2009  
 
 
 
 
                                                                                                               Approved by  
 
 
 
        ______________  
                                                                                                                   Committee Chair 
ii 
 
 
 
 
 
 
 
 
 
 
To my husband Ramesh Jha, my coming baby, my parents, and my family 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
APPROVAL PAGE 
 
 
 
This thesis has been approved by the following committee of the Faculty of the  
Graduate School at the University of North Carolina at Greensboro.  
 
 
 
Committee Chair ______________________________ 
Committee Members ___________________________ 
___________________________ 
 
 
 
 
____________________________ 
Date of Acceptance by Committee  
 
 
____________________________  
Date of Final Oral Examination 
 
 
 
 
iv 
 
ACKNOWLEDGEMENTS 
I would like to express my deep sense of gratitude and sincere thanks to my advisor, Dr. 
Karen S. Katula, Biology Department, UNCG, for her valuable guidance and 
encouragement during my thesis work. During my thesis work she was always ready to 
help me with my experiments and provide me with bright ideas. She was a true mentor 
without whose support this work would have been not possible.  
 
I am also indebted to Matt, Amber and Alison for all the help and co-operation they 
extended to me during my work. Their patience while listening to me and their 
promptness while helping me are commendable. 
 
I would also like to thank Maurice, a previous member of my lab, for helping me with 
experimental techniques and my colleague Avik, for his support. 
 
Last but not least I would like to convey my special thanks to my committee members 
Dr. John Tomkiel and Dr. Yashomati Patel for their support and advices during my work 
to make it a successful thesis. 
 
 
 
v 
 
TABLE OF CONTENTS 
Page 
LIST OF TABLES……………………….................................................................... vii 
LIST OF FIGURES………………………………………………………………….. viii 
CHAPTER  
I. INTRODUCTION……………………………………………………………... 
Project Overview………………………………………………………. 
1 
2 
II. BACKGROUND………………………………………………………………. 
Folate pathway………………………………………………………… 
Folate deficiency and cellular consequences………………………….. 
NF-κB pathway………………………………………………………... 
Reactive oxygen species, homocysteine and NF-κB activation…..…… 
Relationship between folate deficiency, NF-κB and Reactive 
  Oxygen Species (ROS)………………………………………………. 
 
3 
3 
5 
6 
10 
 
11 
III. MATERIALS AND METHODS……………………………………………… 
Cell Lines……………………………………………………………… 
Preparation of Custom Medium……………………………………….. 
Cell Culture……………………………………………………………. 
Western Blot Analysis…………………………………………………. 
ROS Assay…………………………………………………………….. 
Immunofluorescence…………………………………………………... 
NF-κB activity and Luciferase Assay…………………………………. 
Quantification of DNA………………………………………………… 
RT- PCR……………………………………………………………….. 
 
12 
12 
12 
13 
14 
16 
16 
17 
18 
18 
 
 
 
 
 
 
vi 
 
IV. RESULTS…………………………………………………………………….. 
NF-κB acivity in folate deficient and sufficient cells…...…………….. 
No difference in NF-κB protein levels in folate deficient and 
  sufficient cells………………………………………………………... 
No difference in NF-κB Localization in folate deficient and 
  sufficient cells……………………………………………………....... 
Folate deficient cells have higher levels of ROS…………………....... 
 
19 
19 
 
23 
 
25 
28 
V. DISCUSSION………………………………………………………………... 
Increase in NF-κB activity in folate deficient cells………………........ 
No change in levels of NF-κB protein or nuclear localization in 
  folate deficient cells………………………………………………….. 
Increase in ROS in folate deficient cells………………………………. 
Possible mechanism for increase NF-κB acivity in folate deficient  
  cells…………………………………………………………………... 
 
33 
33 
 
35 
37 
 
38 
REFERENCES……………………………………………………………………... 40 
APPENDIX A. DMEM CUSTOM MEDIUM……………………………………... 44 
 
 
 
 
 
 
 
vii 
 
LIST OF TABLES 
Page 
Table 1. Fold change in NF-κB activity in folate deficient and sufficient cells, 
      stimulated with TNF-α…………………………………………………… 
 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viii 
 
LIST OF FIGURES 
Page 
Figure 1. Major folic acid pathway………………………………………………….. 5 
 
Figure 2. NF-κB signal transduction pathway……………………………………...... 
 
9 
Figure 3. Alteration in NF-κB activity in folate deficient and sufficient cells………. 
 
22 
Figure 4. Relative change in cyclin D1 transcripts…………………………………... 
 
23 
Figure 5. Western blot of NF-κB and tubulin ……………………………………….. 
 
24 
Figure 6. Fold change in NF-κB protein level……………………….………………. 
 
25 
Figure 7. Immunofluorescence staining for NF-κB………………………………….. 
 
27 
Figure 8. Nuclear localization of NF-κB…………………………………………….. 
 
28 
Figure 9. ROS assay of NIH3T3 cells grown in folate deficient and sufficient 
       medium for 11 days……………………………………………………… 
 
 
30 
Figure 10. Overlay of histogram plots of ROS assay for the NIH3T3 cells at  
                    day 7 (A) and day 11 (B)……………………………………………….. 
 
 
32 
Figure 11. Possible relationship between folate deficiency and NF-κB 
                    activation……………………………………………………………….. 
 
 
38 
 
1 
 
CHAPTER I 
I
TRODUCTIO
 
 
 
 
Vitamins and minerals are indispensable components of the human diet. Most 
vitamins are not sufficiently synthesized by humans and must be obtained from the diet. 
They have diverse biochemical functions ranging from enzyme co-factors, antioxidants, 
hormones, and regulators of cell and tissue growth and differentiation. 
Folate is a water soluble B vitamin that serves as a methyl donor in the synthesis 
of nucleotides and methionine. Folate deficiency has been associated with numerous 
health problems, including developmental defects, neurological diseases and cancer. The 
relationship between folate deficiency and human disease has not been thoroughly 
defined. 
Our preliminary results and limited published data indicate that NF-κB activity 
increases in folate deficient cells. NF-kappa B (NF-κB) is a cytosolic dimeric 
transcription factor that responds to a variety of stimuli. It regulates expression of genes 
involved in immune response, cell survival, and cell growth. An increase in NF-κB 
activity may contribute to the health defects associated with folate deficiency. However, 
the relationship between folate deficiency and NF-κB expression has not been fully 
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explored. The purpose of this study was to provide an analysis of NF-κB activity in folate 
deficient cells and elucidate the mechanism leading to the alteration in NF-κB activity. 
Project Overview 
In this study, the effects of folate deficiency on NF-κB were analyzed in a 
fibroblast (NIH3T3) and a normal human colon epithelial (FHC) cell lines. NF-κB 
protein levels, activity, and cellular localization were determined in cells grown in folate 
deficient and sufficient medium, stimulated with and without TNF- α, a NF-κB inducer. 
The levels of homocysteine and ROS were determined in the same cell lines grown in 
folate deficient and sufficient medium. The mRNA levels of NF-κB target genes, Cyclin 
D1, were analyzed in a fibroblast cells grown in folate deficient and sufficient medium. 
This study is significant as it provides further understanding of the mechanism by 
which folate deficiency increases the risk of cancer and possibly other human health 
conditions.  Folate deficiency is one of the few dietary components proven to be 
associated with numerous health conditions, yet the mechanism of this relationship is still 
not completely known.  
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CHAPTER II 
BACKGROUD 
 
 
Folate pathway 
 Folate is a water soluble vitamin B that can only be obtained from diet. It is found 
in green leafy vegetables, yeast extracts, citrus fruit, fortified cereal, wheat germ, bread 
and potatoes (Lucock, 2000). Folate is essential in maintaining normal cell division, as it 
functions as a coenzyme in de novo biosynthesis of purines and thymidylate. As such, it 
is required for DNA replication and DNA repair (Shanebeck et al, 1995). It is also 
required for the synthesis of certain amino acids, most importantly, methionine. Dietary 
folate predominantly exists as 5-methyl tetrahydrofolate. The folate is transported across 
the enterocytes brush border membrane by specific carriers involving an anion exchange, 
and enters into the plasma.  After absorption the dietary folate is released into portal 
circulation. The liver plays a central role in maintaining serum folate levels. Plasma 
folate is bound to several low affinity binding proteins, mainly albumin, and enters blood 
circulation. Serum plasma folate is transported into each cell by the cell surface 
transporter FBP (Folate binding protein) and FcoT (Folate co-transporter). 
Fig. 1 shows the intracellular folic acid metabolic pathway. In brief, intracellular 
folate is converted into 7,8-dihydrofolate (DHF), which is converted into tetrahydrofolate 
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(THF) by dihydrofolate reductase (DHFR). THF is converted into 5,10-
methylenetetrahydrofolate and is then converted into 5-methyl-tetrahydrofolate by 5,10-
methylenetetrahydrofolate reductase (MTHFR). The metabolite 5,10-
methylenetetrahydrofolate is used in the conversion of deoxyuridylate monophosphate 
(dUMP) into deoxythymidylate monophosphate (dTMP), an essential nucleotide required 
in DNA synthesis.  The metabolite 5-methyl-tetrahydrofolate is required for the 
conversion of homocysteine into methionine, which in turn is converted into S-
adenosylmethionine (SAM), the only methyl donor for all the intracellular methylation 
reactions, including, methylation reactions of DNA and protein (Ulrich, 2005). 
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Fig. 1. Major folic acid pathway (Modified form of Stokstad, 1967). TNF- 
Tetrahydrofolate, DHFR- Dihydrofolate reductase, MTHFR- 5,10-
methylenetetrahydrofolate reductase, TMP- Thymidylate monophosphate, dUMP- 
deoxyuridylate monophosphate, TS- Thymidylate synthase, MetSynB12- Methionine 
synthase, SAM- S-adenosylmethionine, SAH- S-adenosylhomocysteine. 
 
 
 
Folate deficiency and cellular consequences 
 Folate deficiency has been associated with DNA strand breaks, chromosomal 
gaps and breakages, increased level of dUMP, which in turn leads to increased uracil 
misincorporation into DNA, impaired DNA repair and increased mutations (Blount et al, 
1997). The consequence of these alterations leads to the loss of DNA integrity and 
stability (Blount et al, 1992).  
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 Folate is essential for the transfer of one-carbon units in the de-novo synthesis of 
nucleotides (Blount et al, 1997). Folate deficiency leads to low levels of cytosolic N
5
,N
10
-
methylene tetrahydrofolate (folate cofactor for thymidylate synthase) resulting in 
decreased synthesis of dTMP and an increase in the cellular dUMP/dTMP ratio. The 
consequence of which will be reduced incorporation of dTMP into DNA and increased 
dUTP misincorporation into DNA (Goulian et al, 1980; Das and Herbert 1989; 
Wickramasinghe and Fida 1994). Normally, DNA repair mechanisms remove the 
misincorporated uracil, but due to the large amount of uracil a catastrophic repair cycle is 
established. The uracil removed from DNA leaves behind transient-single strand breaks. 
These nicks can ultimately induce the formation of double strand breaks (Dianov et al, 
1991), which are more difficult to repair and therefore more hazardous to the cell. 
 Folate deficiency also leads to a reduction in remethylation of homocysteine to 
methionine leading to reduced SAM, the only methyl donor for all the cellular 
methylation reactions. Consequently, there is decreased methylation. Reduced SAM due 
to folate deficiency has been found to lead to genome wide DNA hypomethylation and in 
some studies cause activation of oncogenes and malignant transformation (Duthie et al, 
2004). For example, rats fed on a diet devoid of folate displayed increased global 
hypomethylation especially in the liver (Pogribny et al, 2004). Global hypomethylation, 
particularly of repetitive elements, is a common epigenetic event during early stages of 
carcinogenesis (Ehrlich, 2005; Yamada et al, 2005). A decreased SAM/SAH ratio also 
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results in hypermethylation of CpG islands of certain tumor suppressor genes (Kim 2004; 
Park et al, 2005). 
 F-κB pathway 
           NF-κB is a dimeric transcription factor. It is a membrane of protein family sharing 
a highly conserved N-terminal dimerization domain and a DNA binding domain (Rel 
homology domain) (Gilmore, 1990).  Functionally, NF-κB is widely conserved from fruit 
fly to human and also exits in Cnidarian and Porifera (Gilmore, 2006). Mammalian NF-
κB has five members: RelA, RelB, c-Rel, p50/p105, p52/p100 (Gilmore, 2006). NF-κB is 
activated by a wide variety of stimuli such as stress, cytokines, free radicals, UV 
radiation and antigens. NF-κB regulates the expression of genes involved in immune 
response, cell growth control and cell survival regulation (Hayden and Ghosh, 2004). 
Such genes include cytokines, chemokines, Cyclin D1, Cyclin E, CDK2, c-MYC, 
antiapoptotic proteins, Bcl-2, IL-1/6, VEGF, metalloproteinases, MMP2/13, MMP2/9, 
TNF-α, IL-8 and MCP-1. 
NF-κB normally resides as a cytosolic protein bound to the inhibitor IκΒ, a 
protein kinase having ankyrin repeats. There are several IκΒ proteins. These proteins 
interact with the NF-κB nuclear localization signal stopping transport of NF-κB into the 
nucleus. In response to different stimuli there are two pathways that may lead to NF-κB 
activation. The canonical and non-canonical pathway. The canonical pathway is the most 
common. In the canonical pathway  the stimuli leads to the activation of the IKK 
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complex, containing catalytic subunits IKKα / IKKβ and scaffold regulator sensing 
protein NEMO (IKKγ). Generally, the stimulating ligand binds to the cell surface 
receptor, in this case either TNFR or TRAF. These then recruit the IKK complex. This 
activated IKK complex then phosphorylates IκB at two specific serine residues, leading 
to its ubiquitination and proteosomal degradation. NF-κB becomes free and is 
translocated to the nucleus and as a dimer activates different target genes. NF-κB is the 
regulator of its own inhibition in that it activates the revival of IκΒ  (Hoffmann and 
Baltimore, 2006). 
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       Fig. 2.  NF-κB signal transduction pathway (Modified from Gilmore, 2006) 
 
 
 
Misregulation of NF-κB plays a role in promoting oncogenesis (Baldwin, 2001).  
The NF-κB pathway remains constitutively activated in human colorectal carcinoma 
tissues (Ahmed et al, 2006). NF-κB has been found to be upregulated in various cancers 
such as T-cell lymphomas, chronic lymphocytic leukemias, myelomas and B-cell 
lymphomas (Courtis and Gilmore, 2006), breast cancer (Ahmed et al, 2006), and prostate 
cancer (Huang et al, 2001). It has also been associated with Huntington’s disease 
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(Khoshnan et al, 2004) and Alzheimer’s disease (Collister and Albensi 2005). 
Misregulation of NF-κB is associated with autoimmune disease, inflammatory diseases 
and improper immune development (Albensi and Mattson 2000). 
Reactive oxygen species, homocysteine and F-κB activation 
 Oxidative stress occurs due to lack of balance between reactive oxygen species 
(ROS) production and the ability of biologically system to detoxify or repair the reactive 
intermediates produced. ROS are oxygen centered free molecules that include oxygen 
ions, peroxides and hydroxyl free radicals and often are described as free radicals or non-
radicals. ROS are the outcome of byproducts of normal oxygen metabolism and most of 
the time play an important role in cell signaling. Certain circumstances like stress caused 
by ultraviolet rays, hypoxia, X-rays and heavy metals cause higher levels of ROS that 
results in significant cellular damages. 
Homocysteine (Hcy) is a sulfhydryl compound and an intermediate in the folate 
pathway (Fig 1). It is capable of acting catalytically with transition metal ions to form 
hydrogen peroxide, oxygen radicals and homocysteinyl radicals (Starkebaum et al, 1986; 
Olszewski et al, 1993; Tapiero et al, 2001).  
 NF-κB is a redox sensitive transcription factor. It has been demonstrated that 
ROS works as a secondary messenger for NF-κB activation (Bowie and O’Neill, 2000). 
Some groups have reported that hydrogen peroxide can activate the IKK complex in 
human bronchial epithelial cells and HeLa cells (Jaspers et al, 2001; Kamata et al, 2002). 
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In fact, in HeLa cells treatment with hydrogen peroxide resulted in phosphorylation of 
Ser 180 and Ser181 of IKKα, hence activation of the IKK complex and release of NF-κB 
(Kamata et al, 2002). Chen and Green (2004) in their review also mentioned that several 
RelA phosphorylating kinases can be directly activated by ROS, which can result in 
enhanced NF-κB activity. Other studies have shown that oxidative stress can promote 
translocation of NF-κB dimers in the nucleus either by promoting phosphorylation and 
subsequent degradation of IκBα (Karin, 1999) or by phosphorylation of IκBα at a 
tyrosine residue which facilitates the dissociation of IκBα from NF-κB without 
proteosomal degradation (Imbert et al, 1996; Koong et al, 1994; Takada et al, 2003). 
Relationship between folate deficiency, F-κB and Reactive Oxygen Species (ROS) 
 In one study, folate deficiency was shown to cause a drastic increase in Hcy 
production in Hep G2 cells (Chern et al, 2001). A high level of Hcy could be suppressed 
by addition of exogenous folate. Fig 1 shows the interconnection between demethylation 
of 5-methyl-THF to THF and remethylation of homocysteine to methionine. A deficiency 
in folate will cause reduced methylation of homocysteine to methionine, resulting in 
accumulation of homocysteine. Folate deficiency has been shown to increase the level of 
serum homocysteine leading to occlusive vascular disease (Frosst et al, 1995). Clinical 
studies for the Alzheimer’s disease (AD) also suggest that folate deprivation causes an 
increase in ROS and an increase in homocysteine generation (Ho et al, 2003). Another 
study on human intestinal epithelial line, Caco-2 cell line showed that folate deficiency 
leads to reduction in homocysteine remethylation and an increase in intracellular 
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homocysteine (Townsend et al, 2004). As previously discussed, accumulated 
homocysteine has been shown to stimulate NF-κB activity. In addition, the effects of 
homocysteine on NF-κB activity were shown to be nullified by addition of folic acid and 
apocynin (Au-Yeung et al, 2006). In this study, pretreatment of macrophages with folic 
acid (200ng/ml) abolished the Hcy-induced IκBα phosphorylation and NF-κB activation.  
 One mechanism by which folate deficiency and increased homocysteine may be 
affecting NF-κB is by increasing reactive oxygen species (ROS). ROS has been shown to 
increase in cells with higher than normal levels of homocysteine (Zhang et al, 2006). In 
another study, ROS levels were almost 8-fold higher in folate deprived neurons (Ho et al, 
2003). Based on these findings, a possible mechanism by which folate deficiency alters 
cell function is increased homocysteine, leading to increased ROS and activation of NF-
κB. Activated NF-κB would be expected to lead to altered gene expression, having a 
profound effect on cell function. 
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CHAPTER III 
MATERIALS AD METHODS 
 
 
Cell Lines 
NIH3T3, a mouse fibroblast cell line, was originally obtained from the American 
Type Culture Collection (ATCC). NIH3T3 cells stably transfected with the plasmid pNF-
κB-TA-LUC (Clontech) was previously constructed in the lab. This plasmid contains four 
tandem copies of the NF-κB consensus sequence upstream of a minimal TA promoter 
PTA, composed of the TATA box derived from Herpes simplex virus thymidine kinase 
(HSV-TK) promoter. Downstream from the PTA is the coding region of the luciferase 
firefly gene.  
Preparation of Custom Medium 
Delbecco’s Modified Eagle Medium (DMEM) required for growing NIH 3T3 
cells under folate deficient and folate sufficient conditions was prepared using the 
formulation listed in Appendix A minus folic acid. The components were added to and 
mixed in 500 ml of distilled water for three to four hours. The volume was adjusted to 2 
liters and the medium was divided equally into two portions. To one portion folic acid (4 
mg/L) was added. To the other portion folic acid was not added. The medium was filter 
sterilized with a 0.20 µm filter. To prepare complete medium, 50 ml of dialyzed calf 
serum and 5 ml of Penicillin/Streptomycin (5,000 IU/ml and 5,000 µg/ml) was added to 
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450 ml of DMEM. This prepared medium was referred to as DMEM Complete. The 
medium with folic acid was referred to as DMEM Complete WITH (WITH) and the 
medium without folic acid was DMEM Complete NO (NO).  
The DMEM medium for the ROS assay was prepared in the same way as 
explained above with the exception that phenol red was not added.  
Cell Culture 
NF-κB-LUC-3T3 cells were grown in a T-75 flask with DMEM Complete 
medium until there were enough cells for replating. The cells were maintained at a 
subconfluent density.  The cells were plated at a density of 5.6 X 10
5
 in T-75 flask with a 
total volume of 12 ml DMEM Complete. 10 µl of G418 (200 mg/ml) was added to the 
flask. Cells were grown in a 37
0
C incubator with 5% carbon dioxide and 95% air. When 
the cells were approximately 80-90% confluent, they were collected and counted. The 
cells were washed once with 5 ml Hank’s, trypsinized with 4 ml of 1X Trypsin-EDTA 
(0.05% Trypsin, 0.053 mM EDTA) for 1-2 minutes. 4 ml of DMEM Complete medium 
was added to the flask. The solution was transferred to a 15 ml Falcon tube and 
centrifuged in a clinical centrifuge at setting #3 for 5 minutes. The cell pellet was 
resuspended 5 ml DMEM Complete NO medium and an aliquot was removed for 
counting using a haemocytometer. The cells were again replated in two T-75 flasks at a 
density of 5.6 X 10
5
 in either DMEM Complete WITH folate or DMEM Complete NO 
folate and incubated in the cell culture incubator. This day was counted as day 0. For 
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ROS studies, cells were grown in DMEM Complete WITH and NO, phenol red free 
medium.  
For the day 7 time point reactive oxygen species (ROS) studies, the cells were 
collected and replated on day 6 in a 6-well plate with 4 X 10
5
 cells per well in either 
DMEM Complete WITH medium, no phenol red or DMEM NO medium, no phenol red. 
For NF-κB activity, cells were plated at a density of 3 X 10
4
 cells per well in 48-well 
plates in either DMEM Complete WITH medium or DMEM Complete NO medium. The 
remaining cells were replated in separate T-75 flasks containing either DMEM Complete 
NO medium, no phenol red or DMEM Complete WITH medium, no phenol red with a 
cell density of 5.6 X 10
5
 brought to a final volume of 12 ml with 10 µl of G418 (200 
mg/ml) added.  For the day 11 time point, the cells were collected, counted and replated 
on day 10 as previously described for day 7.  
Western Blot Analysis  
Cells for Western Blot were treated with and without TNF-α (1.25 ng/ml) for 4 
hours and then washed with phosphate buffered saline (PBS). 200 µl of 2X SDS lysis 
buffer (4% SDS, 20% glycerol, 100 mM Tris-HCl, pH 6.8, 5 mM DTT) with Protease 
Inhibitor Cocktail (Complete Mini, Roche, Inc.) was added to the cells and left on the 
rocker for 15 minutes. The cells were scraped off the plate, transferred to microfuge tubes 
and centrifuged at 10K for 10 minutes at 4
0
C. Supernatants were transferred to clean 
microcentrifuge tubes, labeled, and all samples were stored at -80
0
C. Protein content of 
the samples were determined by using the Pierce 660 nm Protein Assay kit.   
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 An equal amount of cellular protein from each sample was loaded into separate 
wells of an acrylamide gel (10%). Prestained molecular weight markers (Prosieve, 
Catalogue. #50550) were loaded into one lane of the gel. Electrophoresis was performed 
at a constant 21 mA for 3 hours. After electrophoresis, the protein was transferred to a 
nitrocellulose membrane using a standard protocol. The blot was stained in Ponceau S 
(1% Ponceau S in 1% acetic acid diluted 1:10 with ddH20) to visualize protein and 
confirm transfer and equal loading of the samples. The blot was incubated for an hour in 
5% dry milk dissolved in Tween-Tris Buffered Saline (TTBS) (0.15M NaCl, 0.01M Tris 
pH 8.0, 0.05% Tween 20). A 1:500 dilution of mouse anti-NF-κB (Sigma-Aldrich, 
catalogue # 046K4852) antibodies in 1% dry milk in TTBS was added to the blots and 
left for an hour. The nitrocellulose membrane was then washed in TTBS 3X for 5 
minutes each wash and once for 15 minutes. A 1:10,000 dilution of goat anti-mouse 
horseradish peroxidase (HRP) (Sigma-Aldrich, catalogue #A3673) in 1% dry milk 
contained in TTBS was added to the blot for 1 hour. The blot was washed again 3X in 
TTBS for 5 minutes each wash and one time for 15 minutes. The HRP on the 
nitrocellulose membrane was detected using the Pierce Supersignal West Pico 
Chemiluminescent detection kit. The BioRad Chemi Boc DOCX RS imager and Quality 
One software was used for blots imaging and quantification.     
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ROS Assay 
Cells were collected by trypsinization, counted, and replated in 6-well plates in 
phenol red free medium at a density of 4 X 10
5
 cells. Next day, the medium was changed 
in appropriate wells and replaced with DMEM Complete NO or WITH medium (without 
phenol red). The cells were treated with and without 100 µM H2O2 by adding the 
appropriate amount of 100 mM H2O2. The cells were incubated for an hour at 37
0
C. After 
treatment, the cells were washed once with 2 ml PBS and once with 2 ml Hank’s buffer. 
After washing, the cells were trypsinized and collected by centrifugation. The pellets 
were resuspended in either PBS containing 10 µM C400 ROS compound (Invitrogen) or 
just PBS. After ten minutes cell are analyzed by a BD FACSCalibur flow cytometer 
(settings: P1-E00, P2-310, P3-425, P4-375, P5-650, FL1H-15). Quantification of the 
resulting data was carried out by using the Summit 4.x software.    
Immunofluorescence 
NF-κB-LUC-3T3 cells were grown on circular coverslips in 24-well plates for 
performing immunofluorescence. The cells were replated at a density of 5 X 10
4
 cells per 
well a day before the time point (day 11) and incubated overnight. The medium on the 
cells were replaced with DMEM Complete NO and WITH medium, containing either 
TNF-α or no TNF-α at 1.25 ng/ml. Cells were incubated for 24 hours. The cells were 
washed 1X in PBS and fixed directly in the 24-well plate with 1 ml 2% formaldehyde in 
phosphate buffered saline (PBS) for 15 minutes at room temperature. After fixing, cells 
were washed two times with 500 µl PBS for five minutes per wash. Cells are then stored 
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in 1 ml PBS at 4° C. Cells were permeabilized with 400 µl 0.25% Triton X-100 diluted in 
PBS for 5 minutes. After permeabilization, cells were washed three times with 500 µl 
PBS. 65 µl of anti-NF-kB antibody (Sigma-Aldrich, catalogue # 046K4852) was added 
directly onto the cells and incubated at 37° C for 1 hour. Following incubation, cells were 
washed three times with PBS for 5 minutes per wash. 95 µl of a secondary antibody, goat 
anti-mouse IgG with fluoroform Alexa 488 (Invitrogen, catalogue# A11001) was added 
and the samples incubated at room temperature for one hour in the dark. After incubation 
the cells were washed three times with 500 µl PBS for five minutes per wash. Nuclei 
counterstaining was performed with 300 µl of a 1:100,000 dilution of DAPI for 5 minutes 
at room temperature in the dark. Cells were then washed twice with 500 µl PBS for 5 
minutes. Coverslips were mounted on glass slides using Dako Cytomation Fluorescent 
Mounting Medium and allowed to sit in the dark overnight. Cells were then imaged by 
using confocal microscopy (Olympus FV500) and the Fluoview imaging software 
(Olympus).  Quantification of imunofluorescent signal was obtained using Image J 
software. Average nuclear signal per unit area was measured. 
 
F-κB activity and Luciferase Assay 
Cells were collected by trypsinization, counted, and replated in 48-well plates at a 
density of 3 X 10
4
 cells. The next day, DMEM Complete NO and WITH medium, with 
and without 1.25 µg/ml TNF-α, was added to the respected labeled wells and incubated 
for 4 hours in the cell culture incubator. After incubation, the medium was removed and 
cells were washed once with PBS.  100 µl of 1X Cell Lysis Buffer (Promega, Inc.) was 
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added and incubated at 37
0
C for 15 minutes. The cells were stored at -80
0
C. After 
collection of all samples at days 7 and 11, luciferase was measured using the Promega 
Luciferase Assay System. 30 µl of cell lysate was pipeted into luminometer tubes and 
placed in a Berthold/B950/luminometer. Samples were read for 10 seconds and relative 
light units (RLU) recorded. Variation in cell number was accounted for by measuring 
DNA content and standardizing luciferase results to DNA.  
Quantification of DA 
Cells were collected and prepared as described in luciferase assay. 10 µl of each 
sample was transferred into 96-well plate. 50 µl of a DNA binding dye (Invitrogen, 
CyQuant NF Cell Proliferation Assay) diluted 1:750 in 1X HBSS is added to each well. 
All samples were then incubated at 37
0 
C for 15 minutes and covered with aluminium 
foil. The sample DNA content (fluorescence) was measured on BIO-TEK Synergy HT 
microplate reader at excitation 485 nm and emission 520 nm using the KC4 software. 
RT-PCR 
 Cells for RT-PCR were collected by scraping the cells into PBS. The cells were 
pelleted by centrifugation and washed 1X in PBS and quick frozen in liquid nitrogen. 
Cell pellets were stored at -80
0
C. RNA was isolated using the SU Total RNA Isolation 
System (Promega). The RNA was converted to cDNA using the Quanti Tect Reverse 
Transcription kit (Qiagen, Inc.). Mouse cyclin D1 and GAPDh, primers were obtained 
from Applied Biosystem. RT-PCR was conducted using Taqman and a Applied 
Biosystems Stepone Real-Time PCR system.  
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CHAPTER IV 
RESULTS 
 
 
 
F-κB activity in folate deficient and sufficient cells 
Based on the previous findings (Au-Yeung, Yip et al. 2006) and our preliminary 
results (Katula lab) showing altered NF-κB activity due to folate deficiency, we decided 
to compare NF-κB activity in folate sufficient and deficient cells. It was expected that the 
NF-κB activity would increase. 
  NIH3T3 cells containing a NF-κB reporter construct (NF-κB-LUC-3T3 cells) 
were used as an experimental cell line to assay for NF-κB activity. The cells contain the 
plasmid pNF-κB-TA-LUC (Clontech), which contains four tandem copies of the NF-κB 
consensus sequence upstream of a minimal TA promoter PTA, composed of the TATA 
box derived from Herpes simplex virus thymidine kinase (HSV-TK) promoter. 
Downstream from the PTA is the coding region of the luciferase firefly gene. This plasmid 
responds to increased NF-κB activity by producing more luciferase mRNA. 
 The NF-κB-LUC-3T3 cells were grown for 7 and 11 days in folate deficient and 
sufficient medium to appropriate number. At each time point, cells were treated with and 
without TNF-α (inducer of NF-κB), collected and assayed for luciferase activity. DNA 
content was determined to control for cell number. 
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Three different trials are shown in Fig. 3. At day 7, two of the trials (1 and 2) 
indicate a higher level of NF-κB activity in the folate deficient cells, with and without 
TNF-α. In contrast, trial (3), indicated no difference between the folate sufficient and 
deficient cells. At day 11, there was greater NF-κB activity in the folate deficient cells in 
comparison to folate sufficient cells for all three trials and with and without TNF-α 
stimulation. This difference was significant for all three trials (Fig. 3). The fold change 
was calculated for each trial, comparing within group changes in NF-κB activity, with 
and without TNF-α. As shown in Table 1, the fold change is less than 2 fold and in 
general, there is no major difference between the folate deficient and sufficient cells. 
 
 
   
Table 1. Fold change in F-κB activity in folate deficient and sufficient cells, 
stimulated with TF-α.  
Experiment 
 
DAYS 
 
WITH +/- 
 
O +/- 
 
1(4 hours) 7 1.49 1.76 
 
11 1.65 1.70 
    
2(4 hours) 7 1.74 1.81 
 
11 1.65 1.49 
    
3(4 hours) 7 1.46 1.43 
 
11 1.87 1.42 
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Fig. 3. Alteration in F-κB activity in folate deficient and sufficient cells. NF-κB 
activity reported as RLU per unit DNA in NIH3T3 cells grown under folate sufficient and 
deficient conditions and either stimulated or unstimulated with TNF-α (1.25 ng/ml; 4 
hours). Error Bar represents standard error (n=12). Brackets represent P value 
comparison. P value less than 0.05 not added. W= With folate; N= no folate. 
 
 
 
An increase in NF-κB activity should lead to changes in the expression of NF-κB target 
genes.  This would provide further support for our finding that NF-κB activity increases 
in folate deficient cells.  In a preliminary study, the level of the NF-κB target gene, cyclin 
D1, was examined by qRT-PCR.  In this experiment, cells were grown in folate sufficient 
(WITH) and folate deficient (NO) medium for 7 and 11 days and treated with and 
without TNF-α.  RNA was isolated from the collected cells, converted to cDNA, and 
analyzed using primers specific to cyclin D1 and GAPDH.  The cyclin D1 values were 
normalized to GAPDH.  As shown in Fig. 4 folate deficient cells display a greater 
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increase in cyclin D1 transcript when stimulated with TNF-α than in folate sufficient 
cells.  This increase is greater at day 7 than day 11.  The folate sufficient cells display 
only a slight increase in cyclin D1 transcripts at day 7 and no increase at day 11. 
 
 
   
 
Fig. 4. Relative change in cyclin D1 transcripts.   Cyclin D1 and GAPDH primers were 
used to amplify the target cDNAs prepared from RNA isolated from folate sufficient and 
folate deficient cells, treated with and without TNF-α (4 ng/mL) for 4 hrs, at days 7 and 
11. The cyclin D1 transcript levels were normalized to GAPDH and fold-change 
comparing without TNF-α to with TNF-α determined.  
 
 
  
o difference in F-κB protein levels in folate deficient and sufficient cells 
The cells were grown in NO and WITH folate medium for 7 and 11 days. On day 
11 cells were also treated with TNF-α (stimulator of NF-κB). Western Blot was 
performed to determine the overall NF-κB protein level. Western Blot analysis (Fig. 5) 
revealed that there was no significant change in NF-κB protein levels on both day 7 and 
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day 11 for cells grown in folate deficient (NO) and folate sufficient (WITH) conditions. 
Also, the protein levels for cells treated with TNF-α (stimulator of NF-κB) showed no 
significant change in either folate sufficient or deficient cells. 
 
 
 
 
Fig. 5. Western blot of F-κB and tubulin. Cells were grown for 7 and 11 days in 
folate sufficient (WITH) and folate deficient (NO) medium. For the day 11 cells, cells 
were treated with and without TNF-α (stimulator of NF-κB) at 1.25 ng/ml for 4 hours. 
Protein samples were prepared and 40 µl per lane analyzed by Western blot for NF-κB 
protein. W= WITH folate; N= NO folate; +T= with TNF-α; -T= No TNF-α; D= day. 
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Fig. 6. Fold change in F-κB protein level. The fold change was determined for Day 7 
and 11 WITH and NO samples and +/- TNF-α of NO and WITH for Day 11. 
 
 
 
o difference in F-κB Localization in folate deficient and sufficient cells 
We found that NF-κB activity increases in folate deficient cells but there is no 
significant change in NF-κB protein levels. One explanation for this result is that more 
NF-κB is localizing to the nucleus in the folate deficient cells. NF-κB cellular localization 
was determined by immunofluorescence. Cells were grown under folate deficient and 
sufficient conditions for 11 days, immunostained with NF-κB, and analyzed by confocal 
microscopy (Fig. 7). Nuclear signal per unit area was quantified. 
 Analysis of immunofluorescent images at day 11 showed that in both the folate 
sufficient and deficient cells, nuclear NF-κB signal is higher in the TNF-α treated cells. 
This is what would be expected. However, there was no significant difference between 
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the WITH folate and NO folate cells after TNF-α stimulation (P<0.01). However, there 
was a slight significant difference between the samples in the unstimulated cells; NF-κB 
was lower in the NO folate cells. 
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 -TFα +TFα 
WITH 
  
 
O 
  
 
Fig. 7. Immunofluorescence staining for F-κB.  Immunofluorescent staining of cells 
grown for 11 days under folate sufficient (WITH) and deficient (NO) conditions and 
either unstimulated or stimulated with TNF-α (1.25 ng/ml) for 4 hours. 
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Fig. 8. uclear localization of F-κB. NIH3T3 cells grown for 11 days under folate 
sufficient and folate deficient conditions. Nuclear localization of NF-κB reported as 
nuclear signal per unit area was determined from images as shown in Fig. 7. and treated 
with and without TNF-α (1.25 ng/ml for 4 hours). Error Bar represents standard error 
with P values (n=32). WITH= with folate; NO= no folate; TNF (-) and (+)= with and 
without TNF-α. 
 
 
 
 Folate deficient cells have higher levels of ROS 
We found that there was an increase in NF-κB activity in folate deficient cells. It 
had been shown that under folate deficiency there is an increase in homocysteine levels 
and reactive oxygen species (ROS) levels (Ho et al, 2003). Another study by Zhang et al, 
2006 showed that homocysteine leads to an increase in ROS resulting in an increase in 
NF-κB activity. Based on these findings one possible mechanism behind the increase in 
NF-κB activity is greater reactive oxygen species. To explore this possibility NIH3T3 
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cells were grown for 7 and 11 day under folate sufficient and deficient conditions without 
phenol red (see Materials and Methods). At each time point, cells were collected, treated 
with and without H2O2 and analyzed for ROS using the ROS sensitive compound C400. 
 Controls were cells (WITH and NO folate) treated with and without H2O2 but 
without addition of C400 compound. As shown (Fig. 9) the level of fluorescence is low 
for both WITH and NO folate cells. It is not clear why the DAY 7 controls were higher 
than the DAY 11, as there was no obvious peak in the 10
2 
region for these cells.
              
 
 At day 7, there was increase in ROS expressed as average fluorescence per cell in 
folate deficient NO cells treated with H2O2 with C400 when compared to folate sufficient 
cells (Fig. 9). There was an unexpected result in which increase in ROS was greater when 
cells were not pre-incubated with H2O2. The reason behind the result was not clear. 
However, the folate deficient NO cells had higher levels of ROS in comparison to the 
WITH cells (Fig. 9).  
At day 11, there was an increase in ROS expressed as average fluorescence per 
cell in folate deficient cells treated with H2O2 with C400. The increase in ROS was more 
on day 11 as compared to day 7 (Fig. 9). The higher levels of ROS in the cells when 
treated without H2O2 with ROS at day 11 were also greater. Again, the explanation for 
the higher ROS in cells not preincubated with H2O2 is unclear. 
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Fig. 9. ROS assay of IH3T3 cells grown in folate deficient and sufficient medium 
for 11 days. Cells were grown in folate sufficient and deficient medium without phenol 
red as described in Materials and Methods. The cells were treated with and without H2O2 
(100 µM) for 1 hour and then incubated with 10 µM of C400 compound. Fluorescence 
was measured in 10,000 cells by flow cytometry. W= With folate; N= no folate. 
 
 
  
The overlay of histogram plots from flow cytometric analysis for days 7 and 11 
support the above result. It was expected that the peak of the histogram graph would 
move to the right in case of increase in ROS. The peak for the cells grown under folate 
deficient condition treated with H2O2 and with C400 moved a little further to the right 
when compared to the cells grown under folate sufficient conditions (Fig. 10). The shift 
to the right was greater on day 11 (Fig. 10). 
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Fig. 10. Overlay of histogram plots of ROS assay for the IH3T3 cells at day 7 (A) 
and day 11 (B). 
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CHAPTER V 
DISCUSSIO 
 
 
 
Folate deficiency has been associated with increased risk of various cancers (Solomon et 
al, 1991), but particularly colorectal cancer (Kim, 2004). NF-κB misregulation has been 
reported to play an important role in promoting oncogenesis (Baldwin, 2001) and has 
been reported to be constitutively activated in colorectal carcinoma (Ahmed et al, 2006). 
There is evidence that folate deficiency results in hyperhomocysteinemia (Townsend et 
al, 2004). Also, accumulated homocysteine due to folate deficiency has been shown to 
stimulate NF-κB activity (Zhang et al, 2006). These findings suggest a relationship 
between folate deficiency and alterations in NF-κB activity.  In this study, we provide 
further evidence that NF-κB activity increases in folate deficient cells and that this 
increase is associated with greater levels of ROS in folate deficient cells. 
Increase in 
F-κB activity in folate deficient cells 
We found that NF-κB activity was higher in both TNF-α stimulated and 
unstimulated folate deficient cell at days 7 and 11 in comparison to folate sufficient cells. 
However, the fold change was not significantly different. This result indicates that TNF-α 
has a similar stimulatory effect on both folate deficient and sufficient cells but the 
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activated NF-κB level is higher in both TNF–α stimulated and unstimulated folate 
deficient cells. NF-κB activity can be increased by external factors such as TNF-α, which 
binds to cell surface receptors and activate the signaling pathway leading to inhibition of 
IKK binding to NF-κB and release of NF-κB.  Our results suggest that folate deficient 
and sufficient cells have similar levels of TNF-α receptor, since the fold-change in 
activity is similar. NF-κB can also be activated by internal factors. Some groups have 
reported that hydrogen peroxide can activate IKK complex in human bronchial epithelial 
cells and HeLa cells (Jaspers et al, 2001; Kamata et al, 2002). In fact, treatment of HeLa 
cells with hydrogen peroxide resulted in phosphorylation of Ser 180 and Ser181 of IKKα 
and activation of the complex, which then activated NF-κB (Kamata et al, 2002). Chen 
and Green (2004) in their review also mentioned that several RelA phosphorylating 
kinases can be directly activated by ROS, which can result in enhanced NF-κB activity. 
Our results indicate that the increased NF-κB activity is likely due to an internal factor, 
based on the finding that unstimulated cells have a higher NF-κB activity. A possible 
experiment would be to determine if there is an increased level of ROS and if IKK is 
phosphorylated to a greater extent in folate deficient cells in comparison to folate 
sufficient cells. 
Several published works can be correlated to hypothesize the role of folate 
deficiency and NF-κB activation. A group has shown that folate deficiency caused a 
drastic increase in Hcy production in Hep G2 cells (Chern et al, 2001). These high levels 
of Hcy could be suppressed by addition of exogenous folate. Other groups have proposed 
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that Hcy is a sulfhydryl compound which acts catalytically with transition metal ions to 
generate hydrogen peroxide (Starkebaum et al, 1986; Olszewski et al, 1993; Tapiero et al, 
2001). Since NF-κB is a redox sensitive transcription factor and ROS works as a 
secondary messenger for NF-κB activation (Bowie and O’Neill, 2000), it is possible that 
folate deficiency can cause similar effects on NF-κB activation. Apart from that, as 
discussed earlier, in the presence of hydrogen peroxide, NF-κB can be activated through 
IKK phosphorylation (Kamata et al, 2002). These findings are consistent with our result. 
Our preliminary data showing that folate deficient cells show a greater increase in 
cyclin D1 transcript levels when treated with TNF-α, supports our finding that NF-κB 
activity increases in folate deficient cells. However, it is not clear why the folate 
sufficient cells did not show a greater increase in cyclin D1 expression when stimulated 
with TNF-α.  It will be necessary to repeat this analysis with a biological replica. 

o change in levels of 
F-κB protein or nuclear localization in folate deficient cells 
Western blot analysis of NF-κB protein in folate sufficient and deficient cells both 
in the presence and absence of stimulator did not show any appreciable difference. This is 
consistent with the known pathway of NF-κB activation. Upregulation in protein activity 
and not protein level is the consequence of NF-kB activation. 
Although NF-κB protein levels in folate sufficient and deficient cells were not 
expected to increase, a change in NF-κB phosphorylation would be expected as the p65 
unit of NF-κB gets phosphorylated at serine 276 as a step towards activation (Zhong et al, 
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1998).  An additional approach to confirm our finding that NF-κB is activated would be 
to detect the level of phosphorylated and unphosphorylated NF-κB using suitable 
antibodies in western blot experiments.   
Immunofluorescence imaging was done to show the localization of activated NF-
κB in the nucleus. In the TNF-α stimulated cells (folate sufficient and deficient cells) a 
higher NF-κB localization was detected than  in unstimulated cells. This was expected 
based on the known model of NF-κB activation.  In comparing nuclear signal per unit 
area of sufficient to deficient cells, we did not find any significant difference. This 
finding was not expected based on our data indicating greater NF-κB activity in folate 
deficiency. One possible explanation for this result could be that the increase in NF-κB 
activity is too small to be detected by immunofluorescence. In fact, the difference in NF-
κB activity between folate sufficient and deficient cells is less than 2-fold. Also, the data 
was calculated per unit area, hence any difference in nuclear size would contribute to the 
per unit area value.  In fact, we have observed that folate deficient cells tend to have 
larger nuclei, which could possibly decrease the per unit area value. 
In order to confirm our findings, we would have to determine the size difference 
in the nuclei of the folate deficient and sufficient cells and take that value into account.  
Also, the total nuclear signal of NF-κB should be determined.  Another approach would 
be to determine the total level of nuclear NF-κB protein by flow cytometry.  This would 
be done by isolating nuclei and detecting the NF-κB by immunolabeling with a primary 
antibody and secondary fluorescent antibody, which can be detected by flow cytometry. 
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Increase in ROS in folate deficient cells 
Using the oxidation sensitive C400 dye we detected the level of ROS in folate 
sufficient and deficient cells. Folate deficient and sufficient controls (without C400) show 
low levels of fluorescence. Folate deficient cells treated with H2O2 and with C400 
showed that there was higher level of ROS than folate sufficient cells. This is what would 
be expected. Our finding is consistent with previous works.  In one study, the authors 
show increased level of ROS in folate deprived cortical neurons and SH-SY-S5 
neuroblastoma cells (Ho et al, 2003). Using a ROS sensitive fluorescent dye DFCD, the 
authors found that there was as much as 8 fold increase in ROS level in cortical neurons, 
when the cells were deprived of folate.  
An unexpected result of this study was the detection of ROS in both folate 
deficient and sufficient cells that were not stimulated with H2O2.  This finding suggests 
that the NIH 3T3 cells in culture are under oxidative stress.  One possibility is that the 
experimental procedure, itself, generates ROS in the cells, since the cells are not fixed.  
Regardless, the higher level of ROS in the folate deficient cells suggests a mechanism for 
the higher NF-κB activity in the folate deficient cells.  
 In order to more clearly define a mechanism, we need to determine the 
homocysteine and hydrogen peroxide levels in folate sufficient and deficient cells. The 
experiment can be repeated in different cell lines to confirm the data. A rigorous 
proteomics assay or micro array assay and RT-PCR can be also done to find all the genes 
or proteins upregulated in the absence of folate. Correlating the mRNA or protein level 
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based on the literature will give more insight in the relationship between folate deficiency 
and NF-κB. 
Possible mechanism for increase 
F-κB activity in folate deficient cells 
We were unable to determine homocysteine in the folate sufficient and deficient 
cells, therefore a role of homocysteine in altering NF-κB activity cannot be negated. 
Previous works have linked homocysteine to increased ROS which activates NF-κB 
(Zhang et al, 2006; Leclerc et al, 2008). We showed that there was an increase in ROS 
level in case of folate deficiency and we also found that NF-κB activity was higher in 
case of folate deficient cells. 
 
 
 
 
 
 
Fig. 11. Possible relationship between folate deficiency and F-κB activation. 
 
 
 
Based on these findings and published data, a possible model for how folate 
deficiency leads to NF-κB activation is presented (Fig. 11).  To confirm this model it will 
be critical to determine levels of homocysteine and H2O2 in a number of different cells.  
Also, the level of phosphosphorylated IKK can be determined by Western blot.  Further 
verification of our finding that NF-κB is activated to a greater level in folate deficiency 
Folate 
deficiency 
NF-κB 
Hcy H2O2 
IKK 
39 
 
cells is required.  This will include repeating the RT-PCR analysis for cyclin D1 and 
possibly other NF-κB target genes.  In addition, as previously mentioned, the level of 
phosphorylated NF-κB can be determined.  
 In summary, we have shown that NF-κB activity increases both in TNF-α 
unstimulated and stimulated folate deficient cells and ROS levels increase in folate 
deficiency. These findings are important in that they suggest that folate deficiency is 
altering cell function and increasing the risk of cancer by affecting the activity of the NF-
κB.  
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APPEDIX A. DMEM CUSTOM MEDIUM 
 
 
 
The following ingredients are combined in water to a volume of 4 liters. The pH of the 
medium is then adjusted to between 7.2 and 7.6 using 1N HCl. Medium is then filter 
sterilized using a 0.2 µm filter. 
Inorganic Salts mg 
CaCl2 2H2O 1059.68 
Fe (NO3)3 9 H2O 0.4 
KCl 1600 
MgSO4 7 H2O (dried) 308.04 
NaCl 25,600 
NaH2PO4 H2O 500 
Amino Acids  
L-Arginine HCl 336 
L-Cystine 192 
L-Glutamine 2336 
Glycine 120 
L-Histidine HCl H2O 168 
L-Isoleucine 420 
L-Leucine 420 
L-Lysine HCl 584 
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L-Methionine 120 
L-Phenylalanine 264 
L-Serine 168 
L-Threonine 380 
L-Tryptophan 64 
L-Tyrosine 288 
L-Valine 376 
Vitamins  
Choline Chloride 16 
Folic Acid 8 
Myo-Inositol 28.8 
Nicotinamide 16 
Pantothenate Calcium 16 
Pyridoxal HCl 16 
Riboflavin 1.6 
Thiamine HCl 16 
Other components  
D-Glucose 18000 
Phenol Red 60 
Sodium Pyruvate 440 
Sodium Bicarbonate 6000 
 
